Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02491099 |
| Title | A Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous Carcinoma (Afatinib) |
| Acronym | Afatinib |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Yale University |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Arizona Cancer Center | COMPLETED | Tucson | Arizona | 85724 | United States | Details |
| Yale New Haven Hospital | RECRUITING | New Haven | Connecticut | 06510 | United States | Details |
| Massachusetts General Hospital | COMPLETED | Boston | Massachusetts | 02114 | United States | Details |